Lexaria Discovers Potential Novel Mechanism From Hypertension Study HYPER-H21-4
KELOWNA, BC / ACCESSWIRE / February 21, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce additional findings from its human…
Lexaria Bioscience: An Undervalued Growth Story
Earlier this year, we highlighted Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) as an undervalued biotech company and want to provide more information on the story. During the last year,…
